跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE
Ucb Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 5, 2024
Approval ID
830471f5c0edc67c
Company
Ucb Pharma
Type
Standard
Approval Details
Approval Id
830471f5c0edc67c
Drug Cima Aemps Name
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE
Register Number
1231780001
Holder Company Name
Ucb Pharma
Marketing Company Name
Ucb Pharma S.A.
Holder Company Detail Path
/organization/ucb-pharma-sa
Marketing Company Detail Path
/organization/ucb-pharma-sa-switzerland
Authorization Date
2024-02-05
Dosage Form
SOLUCIÓN INYECTABLE
Dose
140 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Ucb Pharma
Company Detail Path
/organization/ucb-pharma-sa
Company Information
Pharmaceutical Company Name
UCB S.A.
Name En
UCB S.A.
Country Name
Belgium
City Name
Brussels
Address
Brussels, Belgium
Website
https://www.ucb.com
Active Ingredients
ROZANOLIXIZUMAB
280 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 5, 2024
Approval ID
830471f5c0edc67c
Type
Standard
Back to CIMA-AEMPS Approvals